Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SMILE

Financiado

Cerrado

Slimming and Memory Booster MIcroaLgae Extract

Building up on a successful Phase 1, the French SME MICROPHYT has demonstrated its ability to industrially over-produce specific marine bioactive compounds from selected microalgae. Through innovative and patented processes, it de... ver más

31/07/2019

MICROPHYT

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

MICROPHYT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-07-31

SMEInst-08-2016-2017: Supporting SMEs efforts for the dev...

I+D

Cerrada hace 9 años

0% 68% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

MICROPHYT

1.78M€ | Lider

Proyectos interesantes

AlgaHealth

Medical Technol...

Agriculture and...

71K€ Cerrado

PID2021-122989OB-I00

Medical Technol...

Materials Scien...

248K€ Cerrado

AGL2013-48943-C2-2-R

Medical Technol...

Data Science

Cerrado

SMILE

Medical Technol...

Biotechnology

71K€ Cerrado

PID2021-127362OB-I00

Medical Technol...

Food Technology

182K€ Cerrado

AGL2013-48943-C2-1-R

Medical Technol...

Food Technology

278K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 36 meses Fecha Inicio: 2016-07-01
Fecha Fin: 2019-07-31

Líder del proyecto

MICROPHYT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Building up on a successful Phase 1, the French SME MICROPHYT has demonstrated its ability to industrially over-produce specific marine bioactive compounds from selected microalgae. Through innovative and patented processes, it delivers unequalled concentration of these compounds which have already shown preliminary positive effects in the nutrition & health domains. Leveraging the company initial knowledge and expertise, the SMILE program aim at delivering a ready-for-market and highly effective microalgae-based ingredient for food supplement and nutraceutical applications. This ingredient will target weight management and preservation of cognitive function, two current major societal challenges, through a differentiated and sustainable approach. The successful commercial launch of SMILE Ingredient will depend on its ability to create added-value to the industry customers and to demonstrate full safety and efficacy for the end-user. As outcomes of Phase 2, MICROPHYT will deliver demonstrated and reliable information on the future ingredient and will have secured regulatory compliance in order to market SMILE ingredient in the EU and the USA. SMILE project is of strategic importance for MICROPHYT since it allows the company to extend its expertise from microalgae culture to downstream processes, and thus to market a higher added-value product, addressing consumers’ needs for natural and safe ingredients. As the new MICROPHYT’s star product, SMILE is essential to foster company’s competiveness and to strengthen its position on attractive and profitable market segments. At mid-term, this disruptive innovation has the potential to change the dynamics of food supplement market. With at least two new patents filed, SMILE will represent more than 85% of MICROPHYT’s sales and create 30 jobs by 2022, accelerating and sustaining the company’s growth internationally.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores